| Lydia C Radosevich, PT | |
|
439 Mechem Dr, Ruidoso, NM 88345-6813 | |
| (505) 257-1800 | |
| (505) 257-2319 |
| Full Name | Lydia C Radosevich |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 43 Years |
| Location | 439 Mechem Dr, Ruidoso, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144236258 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1781 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ruidoso Physical Therapy Clinic Inc | 4082667639 | 3 |
News Archive
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug application (NDA) for treprostinil diolamine extended release tablets (oral treprostinil) for the treatment of pulmonary arterial hypertension.
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Individuals with alcohol dependence (AD) often have sleep-related disorders such as insomnia, circadian-rhythm sleep disorders, breathing-related sleep disorders, movement disorders, and parasomnias such as sleep-related eating disorder, sleepwalking, nightmares, sleep paralysis, and REM sleep behavior disorder.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
Two champions of gender equality in medicine and research will be honored by The University of Texas MD Anderson Cancer Center at 4 p.m., today in MD Anderson's Onstead Auditorium.
› Verified 3 days ago
| Provider Name | Ruidoso Physical Therapy Clinic Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265498471 PECOS PAC ID: 4082667639 Enrollment ID: O20050409000000 |
News Archive
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug application (NDA) for treprostinil diolamine extended release tablets (oral treprostinil) for the treatment of pulmonary arterial hypertension.
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Individuals with alcohol dependence (AD) often have sleep-related disorders such as insomnia, circadian-rhythm sleep disorders, breathing-related sleep disorders, movement disorders, and parasomnias such as sleep-related eating disorder, sleepwalking, nightmares, sleep paralysis, and REM sleep behavior disorder.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
Two champions of gender equality in medicine and research will be honored by The University of Texas MD Anderson Cancer Center at 4 p.m., today in MD Anderson's Onstead Auditorium.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lydia C Radosevich, PT 439 Mechem Dr., Ruidoso, NM 88345 Ph: (505) 257-1800 | Lydia C Radosevich, PT 439 Mechem Dr, Ruidoso, NM 88345-6813 Ph: (505) 257-1800 |
News Archive
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug application (NDA) for treprostinil diolamine extended release tablets (oral treprostinil) for the treatment of pulmonary arterial hypertension.
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Individuals with alcohol dependence (AD) often have sleep-related disorders such as insomnia, circadian-rhythm sleep disorders, breathing-related sleep disorders, movement disorders, and parasomnias such as sleep-related eating disorder, sleepwalking, nightmares, sleep paralysis, and REM sleep behavior disorder.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
Two champions of gender equality in medicine and research will be honored by The University of Texas MD Anderson Cancer Center at 4 p.m., today in MD Anderson's Onstead Auditorium.
› Verified 3 days ago
Mrs. Roberta Renee Regalado, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 628 Sudderth Dr, Ruidoso, NM 88345 Phone: 575-257-5820 Fax: 575-257-9560 | |
Mr. Ryan David Biricocchi, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 Mescalero Trl, Ruidoso, NM 88345 Phone: 505-257-5820 Fax: 505-257-9560 | |
Dana M Wade, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1129 Mechem Dr Ste C, Ruidoso, NM 88345 Phone: 575-808-8721 Fax: 575-808-8723 | |
Mr. Ian Christopher Paul, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 Mescalero Trl, Ruidoso, NM 88345 Phone: 575-257-5820 | |
Marla Loree Wall, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 Mescalero Trl, Ruidoso, NM 88345 Phone: 575-257-5820 | |
Ruidoso Physical Therapy Clinic, Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 439 Mechem Dr, Ruidoso, NM 88345 Phone: 575-257-1800 Fax: 575-257-2319 |